[go: up one dir, main page]

GB201016912D0 - Novel combination - Google Patents

Novel combination

Info

Publication number
GB201016912D0
GB201016912D0 GBGB1016912.6A GB201016912A GB201016912D0 GB 201016912 D0 GB201016912 D0 GB 201016912D0 GB 201016912 A GB201016912 A GB 201016912A GB 201016912 D0 GB201016912 D0 GB 201016912D0
Authority
GB
United Kingdom
Prior art keywords
novel combination
novel
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1016912.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to GBGB1016912.6A priority Critical patent/GB201016912D0/en
Publication of GB201016912D0 publication Critical patent/GB201016912D0/en
Priority to AU2011311310A priority patent/AU2011311310A1/en
Priority to IN567MUN2013 priority patent/IN2013MN00567A/en
Priority to JP2013532266A priority patent/JP2013538867A/en
Priority to RU2013115103/15A priority patent/RU2013115103A/en
Priority to SG2013019666A priority patent/SG188575A1/en
Priority to CA2813684A priority patent/CA2813684A1/en
Priority to EP11781829.4A priority patent/EP2624838A1/en
Priority to CN2011800589330A priority patent/CN103249418A/en
Priority to BR112013008362A priority patent/BR112013008362A2/en
Priority to MX2013003816A priority patent/MX2013003816A/en
Priority to PCT/GB2011/051898 priority patent/WO2012046050A1/en
Priority to KR1020137008725A priority patent/KR20130126595A/en
Priority to IL225312A priority patent/IL225312A0/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GBGB1016912.6A 2010-10-07 2010-10-07 Novel combination Ceased GB201016912D0 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
GBGB1016912.6A GB201016912D0 (en) 2010-10-07 2010-10-07 Novel combination
KR1020137008725A KR20130126595A (en) 2010-10-07 2011-10-05 Novel combinations
CA2813684A CA2813684A1 (en) 2010-10-07 2011-10-05 Novel combinations
CN2011800589330A CN103249418A (en) 2010-10-07 2011-10-05 Novel combinations
JP2013532266A JP2013538867A (en) 2010-10-07 2011-10-05 Novel combination
RU2013115103/15A RU2013115103A (en) 2010-10-07 2011-10-05 NEW COMBINATIONS
SG2013019666A SG188575A1 (en) 2010-10-07 2011-10-05 Novel combinations
AU2011311310A AU2011311310A1 (en) 2010-10-07 2011-10-05 Novel combinations
EP11781829.4A EP2624838A1 (en) 2010-10-07 2011-10-05 Novel combinations
IN567MUN2013 IN2013MN00567A (en) 2010-10-07 2011-10-05
BR112013008362A BR112013008362A2 (en) 2010-10-07 2011-10-05 combinations
MX2013003816A MX2013003816A (en) 2010-10-07 2011-10-05 Novel combinations.
PCT/GB2011/051898 WO2012046050A1 (en) 2010-10-07 2011-10-05 Novel combinations
IL225312A IL225312A0 (en) 2010-10-07 2013-03-18 Novel combinations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1016912.6A GB201016912D0 (en) 2010-10-07 2010-10-07 Novel combination

Publications (1)

Publication Number Publication Date
GB201016912D0 true GB201016912D0 (en) 2010-11-24

Family

ID=43304217

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1016912.6A Ceased GB201016912D0 (en) 2010-10-07 2010-10-07 Novel combination

Country Status (14)

Country Link
EP (1) EP2624838A1 (en)
JP (1) JP2013538867A (en)
KR (1) KR20130126595A (en)
CN (1) CN103249418A (en)
AU (1) AU2011311310A1 (en)
BR (1) BR112013008362A2 (en)
CA (1) CA2813684A1 (en)
GB (1) GB201016912D0 (en)
IL (1) IL225312A0 (en)
IN (1) IN2013MN00567A (en)
MX (1) MX2013003816A (en)
RU (1) RU2013115103A (en)
SG (1) SG188575A1 (en)
WO (1) WO2012046050A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150027922A (en) * 2013-09-04 2015-03-13 주식회사 대웅제약 Novel antifungal pyridinylhydrazide derivatives
KR101657678B1 (en) * 2013-11-05 2016-09-20 주식회사 대웅제약 Novel compound, method for preparation thereof, and antifungal composition comprising the same
CN108349999A (en) * 2015-11-16 2018-07-31 埃斯蒂文博士实验室股份有限公司 Oxadiazaspiro compounds for the treatment of drug abuse and addiction
CN109195975B (en) * 2016-09-30 2022-01-04 四川海思科制药有限公司 Diazaspiro [5.5] undecane derivative and application thereof
CN117024499A (en) * 2023-07-17 2023-11-10 陕西汉江药业集团股份有限公司 Preparation method of steroid compound with methylene hydroxyl introduced at 2-position

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8334494D0 (en) 1983-12-24 1984-02-01 Tanabe Seiyaku Co Carbostyril derivatives
ES2165768B1 (en) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa NEW DERIVATIVES OF QUINUCLIDINE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
GB0003154D0 (en) 2000-02-12 2000-04-05 Astrazeneca Uk Ltd Novel compounds
GB0103630D0 (en) 2001-02-14 2001-03-28 Glaxo Group Ltd Chemical compounds
US7045658B2 (en) 2001-03-22 2006-05-16 Glaxo Group Limited Formailide derivatives as beta2-adrenoreceptor agonists
SE0102616D0 (en) 2001-07-25 2001-07-25 Astrazeneca Ab Novel compounds
SE0102617D0 (en) 2001-07-25 2001-07-25 Astrazeneca Ab Novel compounds
CA2458534C (en) 2001-09-14 2011-11-01 Glaxo Group Limited Phenethanolamine derivatives for treatment of respiratory diseases
TWI249515B (en) 2001-11-13 2006-02-21 Theravance Inc Aryl aniline beta2 adrenergic receptor agonists
TW200409746A (en) 2002-07-26 2004-06-16 Theravance Inc Crystalline β2 adrenergic receptor agonist
BR0315234A (en) 2002-10-11 2005-08-23 Pfizer Indole derivatives as beta-2 agonists
DK1556342T3 (en) 2002-10-28 2008-07-21 Glaxo Group Ltd Phenethanolamine derivative for the treatment of respiratory diseases
SE0300091D0 (en) 2003-01-15 2003-01-15 Astrazeneca Ab Novel compounds
SE0300092D0 (en) 2003-01-15 2003-01-15 Astrazeneca Ab Novel compounds
PE20040950A1 (en) 2003-02-14 2005-01-01 Theravance Inc BIPHENYL DERIVATIVES AS AGONISTS OF ß2-ADRENERGIC RECEPTORS AND AS ANTAGONISTS OF MUSCARINAL RECEPTORS
US7317102B2 (en) 2003-04-01 2008-01-08 Theravance, Inc. Diarylmethyl and related compounds
WO2004106333A1 (en) 2003-05-28 2004-12-09 Theravance, Inc. Azabicycloalkane compounds as muscarinic receptor antagonists
TW200526547A (en) 2003-09-22 2005-08-16 Theravance Inc Amino-substituted ethylamino β2 adrenergic receptor agonists
US7345060B2 (en) 2003-11-21 2008-03-18 Theravance, Inc. Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity
GB0402797D0 (en) 2004-02-09 2004-03-10 Novartis Ag Organic compounds
US7745621B2 (en) 2004-05-14 2010-06-29 Boehringer Ingelheim International Gmbh Long acting bronchodilators for the treatment of respiratory diseases
DE102004024453A1 (en) 2004-05-14 2006-01-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg New long-acting bronchodilators for the treatment of respiratory diseases
JP2008501705A (en) 2004-06-03 2008-01-24 セラヴァンス， インコーポレーテッド Diamine β2 adrenergic receptor agonist
US20060002967A1 (en) 2004-07-01 2006-01-05 Smestad Thomas L Resorbable implant with lubricious coating
EP1778626A1 (en) 2004-08-16 2007-05-02 Theravance, Inc. Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
EP1833822A2 (en) 2004-08-16 2007-09-19 Theravance, Inc. Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
GB0425057D0 (en) 2004-11-12 2004-12-15 Pfizer Ltd L-tartrate salt of N-1-adamantyl-2-{3-[(2R)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]eth yl}amino)propyl]phenyl}acetamide
US20060114254A1 (en) 2004-11-26 2006-06-01 Tim Day Volume rendering apparatus and method
WO2006066907A1 (en) 2004-12-21 2006-06-29 Glaxo Group Limited Pharmaceutical formulations
ES2265276B1 (en) 2005-05-20 2008-02-01 Laboratorios Almirall S.A. DERIVATIVES OF 4- (2-AMINO-1-HYDROXYETHYL) Phenol as agonists of the BETA2 ADRENERGIC RECEIVER.
GB0512246D0 (en) 2005-06-15 2005-07-27 Glaxo Group Ltd Novel pharmaceutical
EA016203B1 (en) 2006-03-20 2012-03-30 Пфайзер Лимитед Amine derivatives
ES2296516B1 (en) 2006-04-27 2009-04-01 Laboratorios Almirall S.A. DERIVATIVES OF 4- (2-AMINO-1-HYDROXYETHYL) Phenol as agonists of the BETA2 ADRENERGIC RECEIVER.
TW200808771A (en) 2006-05-08 2008-02-16 Astrazeneca Ab Novel compounds II
GB0613154D0 (en) 2006-06-30 2006-08-09 Novartis Ag Organic Compounds
DE502007006951D1 (en) 2006-08-07 2011-05-26 Boehringer Ingelheim Pharma MEDICINAL COMBINATIONS FOR THE TREATMENT OF RESPIRATORY DISEASES
PE20081358A1 (en) 2006-08-22 2008-10-31 Boehringer Ingelheim Int PHARMACOLOGICAL COMBINATIONS FOR THE TREATMENT OF DISEASES OF THE AIRWAY
JP2010505810A (en) 2006-10-04 2010-02-25 ファイザー・リミテッド Sulfonamide derivatives as adrenergic and muscarinic antagonists
ES2302447B1 (en) 2006-10-20 2009-06-12 Laboratorios Almirall S.A. DERIVATIVES OF 4- (2-AMINO-1-HYDROXYETHYL) Phenol as agonists of the BETA2 ADRENERGIC RECEIVER.
TW200833670A (en) 2006-12-20 2008-08-16 Astrazeneca Ab Novel compounds 569
JO2754B1 (en) 2006-12-21 2014-03-15 استرازينكا ايه بي Indazolyl amide derivatives for the treatment of glucocorticoid receptor mediated disorders
SA08280783B1 (en) 2007-01-11 2011-04-24 استرازينيكا ايه بي Pyridopyrimidine Derivatives as PDE4 Inhibitors
GB0702456D0 (en) 2007-02-08 2007-03-21 Astrazeneca Ab New combination
GB0702457D0 (en) 2007-02-08 2007-03-21 Astrazeneca Ab New combination 666
ES2306595B1 (en) 2007-02-09 2009-09-11 Laboratorios Almirall S.A. NAPADISYLATE SALT OF 5- (2 - ((6- (2,2-DIFLUORO-2-PHENYLETOXI) HEXIL) AMINO) -1-HYDROXYETHYL) -8-HYDROXYCHINOLIN-2 (1H) -ONE AS ADRENERGIC RECEIVER AGONIST BETA2 .
WO2008106016A2 (en) 2007-02-27 2008-09-04 Metrosol, Inc. Prism spectrometer with moveable detector element and with collimated input light
GB0703999D0 (en) 2007-03-01 2007-04-11 Astrazeneca Ab New combination 667
BRPI0813244B8 (en) 2007-06-27 2021-05-25 Astrazeneca Ab compounds derived from pyrazinone, compositions comprising said compounds, use of the compounds in the treatment of lung diseases and intermediate compound
MX2010003698A (en) * 2007-10-04 2010-04-21 Astrazeneca Ab Steroidal [3, 2-c] pyrazole compounds, with glucocorticoid activity.
EA018711B1 (en) 2008-02-06 2013-10-30 Астразенека Аб Diazaspiro[5.5]undecane derivatives as muscarinic receptor antagonists and beta-adrenoceptor agonists for use in the treatment of pulmonary disorders
KR20110010725A (en) 2008-05-13 2011-02-07 아스트라제네카 아베 PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A β2-ADRENOCEPTOR AGONIST
EP2300464A1 (en) 2008-05-13 2011-03-30 AstraZeneca AB Quinuclidine derivatives as muscarinic m3 receptor antagonists
UY32520A (en) 2009-04-03 2010-10-29 Astrazeneca Ab COMPOUNDS THAT HAVE AGONIST ACTIVITY OF THE GLUCOCORTICOESTEROID RECEPTOR
GB0913345D0 (en) 2009-07-31 2009-09-16 Astrazeneca Ab New combination 802

Also Published As

Publication number Publication date
EP2624838A1 (en) 2013-08-14
WO2012046050A1 (en) 2012-04-12
IL225312A0 (en) 2013-06-27
AU2011311310A1 (en) 2013-04-11
IN2013MN00567A (en) 2015-10-09
MX2013003816A (en) 2013-05-01
CN103249418A (en) 2013-08-14
SG188575A1 (en) 2013-04-30
BR112013008362A2 (en) 2016-06-14
RU2013115103A (en) 2014-11-20
JP2013538867A (en) 2013-10-17
CA2813684A1 (en) 2012-04-12
KR20130126595A (en) 2013-11-20

Similar Documents

Publication Publication Date Title
DK3342786T3 (en) Anti-dll3-antistof
AP3107A (en) 5-Alkynyl-pyrimidines
EP2566479A4 (en) Azaindazoles
EP2640189A4 (en) 3-deutero-pomalidomide
EP2534256A4 (en) Novel uses
DK3466977T3 (en) Anti-vla-4-antistoffer
EP2641891A4 (en) Pkc- activator
GB201013207D0 (en) Novel combination
IL225312A0 (en) Novel combinations
EP2571358A4 (en) Combination
EP2572199A4 (en) Combination
GB201001385D0 (en) Cable-tidies
GB201000196D0 (en) Novel combination
GB201001546D0 (en) Knocktop
EP2603078A4 (en) Combination
AU4822P (en) FlatwaxwhiteGL Chamelaucium uncinatum
AU4937P (en) FlatinsulGL Myoporum insulare
AU4932P (en) FlatwaxpinkGL Chamelaucium uncinatum
AU4931P (en) FlatwaxDarkGL Chamelaucium uncinatum
AU4536P (en) TB01 Tibouchina urvilleana
GB201013212D0 (en) Novel combination
GB201013211D0 (en) Novel combination
GB201013214D0 (en) Novel combination
GB201013209D0 (en) Novel combination
GB201005318D0 (en) Novel combination

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)